Drug
Escherichia coli strain nissle 1917 clinical trials
Also written Mutaflor.
- studies test it
- 11
- open now
- 0
- in phase 3
- 2
- first study started
- 2009
How studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
11 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 2
- Phase 4
- 4
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 11
Kangbuk Samsung Hospital (1) · Bogomolets National Medical University (1) · University of Hohenheim (1) · Keimyung University Dongsan Medical Center (1) · GWT-TUD GmbH (1) · Elizabeth Lucas (1) · Charite University, Berlin, Germany (1) · University of Oulu (1)
Studies
Open first, then newest update. How each study uses escherichia coli strain nissle 1917 is read from its arms, and is right about nine times in ten.
Testing it · 11
- Preventing Urinary Tract Infections With E. Coli Nissle:Status unknownPhase 4University of OuluNCT04608851Written as E. coli Nissle
- Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.CompletedPhase 4Kangbuk Samsung HospitalNCT04969679Written as E. coli Nissle 1917 (Mutaflor®)
- Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic EncephalopathyCompletedNot applicableBogomolets National Medical UniversityNCT04787276Written as E.coli Nissle 1917
- Effects of Nutritional Fat on the Growth of Intestinal E. ColiStatus unknownNot applicableUniversity of ZurichNCT03800147Written as "Mutaflor Suspension" (E. coli Nissle 1917)
- E. Coli Nissle in OncologyCompletedPhase 3University of HohenheimNCT02706184Written as E. coli Nissle suspension
- The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter StudyCompletedPhase 4Keimyung University Dongsan Medical CenterNCT02726295Written as E. coli Nissle 1917(Mutaflor®)
- Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type IICompletedPhase 3GWT-TUD GmbHNCT02144948Written as e.-coli-nissle
- Probiotics in the Treatment of Irritable Bowel SyndromeStatus unknownNot applicableUniversity of CopenhagenNCT02953171Written as Mutaflor
- Open Label Trial of Nissle 1917CompletedPhase 1Elizabeth LucasNCT02276508Written as E. coli Nissle 1917
- Prophylaxis of Gastrointestinal Infections With EcNStatus unknownPhase 4Hospital San BartolomeNCT01469273Written as Mutaflor® Suspension
- Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen RhinoconjunctivitisCompletedPhase 2Charite University, Berlin, GermanyNCT01013259Written as Mutaflor